Abstract. The rodent prostate has a complex structure, consisting of a ventral prostate (VP), lateral prostate (LP), dorsal prostate (DP) and anterior prostate (AP), and most studies so far have focused on the VP. Androgen-responsive prostatic secretory proteins, such as prostatein and kallikreins, are mainly produced in the VP, but others are abundant in the LP and DP, though little is known about differences of androgen regulation among the different lobes. Here, the mRNA expression levels of some representative androgen-responsive genes, including those encoding prostatic secreted proteins, were quantitatively determined in each of the prostatic lobes of intact rats and castrated rats treated with testosterone alone or plus flutamide. The results show that the transcriptional regulation of prostatic secretory proteins differs greatly among lobes, generally being more tightly regulated in the VP. A number of growth factor mRNAs were differentially expressed in separate lobes and were regulated by testosterone in a lobe-specific manner. Lobe-specific regulation by androgen was also found for other genes, including the DAD-1 and calreticulin genes. Thus, hormone-dependent transcriptional regulation of prostate genes differs among lobes, and there is also interlobar diversity of basal mRNA expression levels.
RAT prostate models have been used to study androgenregulated gene expression of several prostatic secreted proteins, such as probasin, cystatin-related protein-1 (CRP-1), PSP94 and kallikreins [1] [2] [3] [4] [5] , and differential display PCR and micro-array analysis have recently been applied to identify novel androgen-responsive genes. However, induction of gene expression by androgen in the prostate is not simple, since androgen may directly regulate genes, as well as indirectly influence gene expression by stimulating growth or regeneration of the gland. In the prostate, 'androgendependent' genes have generally been rather simply defined as those whose expression decreases following castration and recovers upon androgen replacement [6] [7] [8] . Moreover, the rodent prostate has a complex structure, consisting of a ventral prostate (VP), lateral prostate (LP), dorsal prostate (DP) and anterior prostate (AP, or coagulating gland) [9] . Most studies have focused on the VP, and the responses could be quite different in the other lobes. The best-characterized androgen-regulated gene is probably probasin in the rat [2, 5] . Although the genomic upstream regions contain consensus androgen-responsive elements (AREs) which are functional promoters in in vitro reporter assay [10] [11] [12] , the mRNA level rapidly decreases after castration only in the VP, but not in the other lobes [4] , suggesting a complexity in androgendependent expression in vivo. Other prostatic secretory proteins, including prostatein, PSP94, kallikreins, cystatin-related protein-1 (CRP1) and SVS2, are also known to be induced by androgen. DAD-1, calreticulin, estrogen receptor β (ERβ) and a number of growth factors, such as IGF-1, EGF and SCGF, have been reported to be regulated by androgen [13, 14] , but the details, such as lobe specificity and time dependency after testosterone administration, have not been examined. The rodent VP is considered to have no counterpart in primates, while the LP and the DP are histologically similar to the human prostate [12] . In experimental prostate carcinogenesis initiated with chemical carcinogens in Noble rats and other rat strains, hormonedependent prostatic adenocarcinomas are found only in the LP, DP and AP [8, [15] [16] [17] . If the rat prostate is to be employed as a human model, more attention should be paid to androgen responses in these lobes.
We therefore examined the mRNA expression levels of androgen-responsive genes, including prostatic secreted proteins, growth factors and other recently identified genes, in the prostate of F344 rats. RNAs isolated from the different prostatic lobes, as well as the seminal vesicle (SV), were subjected to quantitative real-time RT-PCR to analyze the expression levels and to provide an outline view of the overall androgen responsiveness of genes expressed in the prostate gland.
Materials and Methods

Hormones
Testosterone propionate was purchased from Wako Junyaku KK, Osaka, Japan and flutamide from Tokyo Chemical Industry Co., Ltd., Tokyo, Japan.
Animals
Animal experiments were conducted according to 'A Guide for the Care and Use of Laboratory Animals of Hiroshima University'. Male F344 rats were purchased at 10 weeks of age from Charles River Japan Co. (Kanagawa, Japan) and maintained with free access to basal diet and tap water. All animals except those of the intact control group were surgically castrated at 11 weeks of age. To examine the effects of castration, the animals were divided into three groups (consisting of 6 animals each), i.e., intact group and groups castrated 1 and 2 weeks previously. For the testosterone injection experiment, animals were castrated one week previously and divided into 5 groups (6 animals each). Testosterone and flutamide were injected ip and animals were sacrificed after 1, 4, and 24 h (T1h, T-4h, T-24h and T plus flutamide-24h), along with intact control animals. Testosterone propionate and flutamide were dissolved in the vehicle oil, Panacete 810 (Nippon Oils and Fats Co., Ltd., Tokyo), and administered ip at 5 mg/kg body weight and 60 mg/kg body weight, respectively. After treatment, animals were sacrificed at the indicated time points under ether anesthesia and each of the prostate lobes, as well as the SV, was dissected under a microscope, weighed, immediately frozen in liquid nitrogen, and stored at -80°C.
Quantification of mRNAs by real-time RT-PCR
RNA preparation was carried out with a Total RNA Isolation kit (Promega Co., Madison, WI, USA). Total RNA (2 µg) was reverse-transcribed with 200 U of MMLV-RT (Invitrogen Corp., Carlsbad, CA, USA) and 2.5 pmol of oligo-dT primer (Invitrogen) in 25 µl of buffer containing 1 mM dNTP, 100 mM TrisHCl (pH 8.3), 150 mM KCl, 6 mM MgCl 2 , 60 mM dithiothreitol and 5 U/µl RNasin with incubation at 37°C for 60 min.
The real-time PCR method with a QuantiTect Sybr Green PCR kit (Qiagen, Valencia, CA, USA) and an ABI Prism 7700 (PerkinElmer Life Sciences, Boston, MA, USA) was employed for quantitative measurement, following the supplied protocol [18] . Specific primer sets with a Tm of about 59°C were designed for each mRNA ( Table 1 ). The PCR conditions were 15 min of initial activation followed by 45 cycles of 20 sec at 94°C, and 30 sec at 58°C and 40 sec at 72°C. Prior to quantitative analysis, PCR products were prepared separately and purified by gel-electrophoresis. Extracted fragments were used as standards for quantification. The DNA sequences were confirmed with a capillary DNA sequencer, ABI 310 (PerkinElmer Life Sciences). All mRNA contents were normalized with reference to β-actin mRNA.
Serum testosterone levels
Serum testosterone levels were measured with an ELISA kit, purchased from Neogen Corp. (Lexington, KY, USA).
Statistical Analysis
Statistical comparisons were made using ANOVA followed by Scheffe's test.
Results
Body and prostate lobe weights and serum T levels One week after castration, body weights as well as the weights of the prostatic lobes, especially the VP, were significantly decreased ( Table 2 ). The weight of each lobe showed no significant change within 24 h of testosterone administration. Serum T levels were significantly decreased in the castration group and increased within 1 h of testosterone administration, reaching 18 times the intact control level and then decreasing to below the intact control level within 24 h.
Lobe-specific mRNA expression of androgen-responsive genes and androgen receptor (AR) in control prostate Among the prostate-secreted proteins examined, prostatein C3, kallikrein S3 and CRP1 were preferentially expressed in the VP, although substantial amounts of mRNAs for these proteins were also detected in the other lobes (e.g., the prostatein C3 mRNA level was 150 mol/mol β-actin in the VP and 1.5 mol/ mol in the DP) ( Table 2 ). Prominent expression of probasin, PSP94 and SVS2 was noted in the LP and DP at 30-700 times the expression levels of β-actin. In the growth factor category, the SCGF mRNA levels were higher in the DP, while the expression of EGF was high in the AP ( Table 2 ). Expression of DAD1 was equally higher in both the VP and LP compared with the other lobes. Calreticulin and farnesyl diphosphate synthase (FPPS) mRNA levels were 5-10 times higher in the VP than in the other lobes. The ERβ mRNA level in the Table 1 . Quantitative PCR primers for rat genes VP was three times that in the LP or DP, while the level was 1/10 in the AP, and ERβ mRNA was not detectable in the SV. The AR mRNA showed no marked differences in expression among the prostatic lobes, although significantly lower values were obtained for the SV.
Lobe-specific changes in mRNA expression after castration
Castration reduced the mRNA expression of prostate secreted proteins, but the degree of change varied greatly among different lobes and genes ( Table 3 ). The mRNAs of the VP-specific proteins, kallikrein S3, CRP-1 and prostatein C3, almost disappeared after castration. On the other hand, PSP94, SVS2 and probasin were moderately decreased in the LP and DP. IGF-1 and VEGF mRNAs were decreased in the VP, LP and DP, and a decrease in EGF mRNA was noted in all the lobes. SCGF mRNA was considerably reduced only in the DP and LP. DAD-1 was decreased in the VP and LP, while calreticulin and FPPS were prominently decreased only in the VP. ERβ mRNA was significantly decreased in the VP, LP and DP, but not in the AP.
Castration roughly doubled the AR mRNA expression in every lobe.
Lobe-specific changes in mRNA expression after testosterone administration in castrated animals Expression of mRNA and the fold increases over the castration group at 1 and 24 h after testosterone administration are summarized in Table 3 , and graphs of time-dependent change in mRNAs for several genes are presented in Fig. 1 . A VP-specific secreted protein, kallikrein S3, was increased 24 h after T treatment, but not after 1 or 4 h. Even though the expression increased by 10-fold, the absolute mRNA level reached only 1/56 of the intact control level. Similar timedependent changes in mRNA were noted for CRP1 and prostatein C3 (data not shown). Among growth factors, IGF-1 and EGF mRNAs were elevated in a lobespecific manner after testosterone administration. SCGF mRNA was increased in LP and DP at 1 h after testosterone administration, but reverted to the initial level within 24 h (Fig. 1) . In castrated animals, Tdependent short-term induction of mRNA (in 1 or 4 h) was found for some genes in some lobes, e.g., probasin and SVS2 in the VP, SCGF in the LP/DP and calreticulin in all the lobes. Co-administration of flutamide with T for 24 h reversed the T-induced mRNA expression in all cases.
Discussion
The rodent prostate, consisting of four or five separate lobes, is anatomically very different from the human organ [9, 19] . Developmentally, the rodent VP arises from buds in the ventral region of the urogenital sinus and there is no corresponding portion in the adult prostate in humans or other primates [4] . The LP and DP are considered to be homologous to the peripheral zone of human prostate and the AP is similar to the central zone, these lobes being most susceptible to androgen-induced carcinogenesis [16, 20, 21] . Recently, an expression profile study of the mouse prostate revealed that the gene expression patter of the dorsolateral prostate was closest to that of the human prostate peripheral zone [22] . Despite this, the rodent ventral prostate has been most intensively investigated and only limited attention has been paid to other lobes in studies on androgen regulation of genes.
AR is distributed in the target tissues, including the prostate, and mediates androgen regulation of gene expression. Our results confirm that AR mRNA expression is substantial throughout the prostatic lobes. A previous western blotting study showed that different prostatic lobes contain significantly different amounts of AR protein, i.e., the level was 4-7 times higher in the VP than in the LP and DP [23] , whereas the present data indicate that AR mRNA is equally expressed among the lobes. Although AR is primarily under pos- itive androgen control in prostatic tissues, based on ligand-binding assays [24, 25] , the mRNA was downregulated by testosterone administration according to northern blotting analysis, in agreement with our mRNA data. Discrepancy between protein and mRNA levels probably indicates that AR protein levels are partly regulated at the post-translational level in a lobespecific manner. Prostatein, CRP-1 and kallikreins are ventral-specific proteins. Prostatein, known as PBP or prostatic binding protein, consists of two non-identical subunits, each containing three peptides, C1, C2 and C3 [5] . Although PBP was first recognized on the basis of its low binding affinity to steroids, and accounts for 30-50% of secreted proteins in the rat VP, its in vivo function is still unclear. CRP-1 and -2 have been reported to make up 5-10% of the VP secretion [1] . Kallikrein S3, one of the tissue kallikreins (serine proteases), is also abundantly expressed in VP [26] , and has been suggested as a counterpart for human prostatic-specific antigen or PSA [27] . Our data indeed demonstrated high levels of expression of these genes, with about 100 fold higher amounts of mRNA than that of a housekeeping gene, β-actin, used as an internal control in the present study. Similarly, mRNAs of probasin, SVS2 and PSP94 were preferentially expressed in the LP and DP, while substantial amounts of these mRNAs were also expressed in the AP.
Several growth factor families have been implicated in normal prostatic growth and differentiation, as well as in malignant changes, with interaction between stromal and epithelial cells [28] . Among them, IGF-1, EGF and SCGF have been reported to be regulated by androgen [7, 29, 30] . IGF-1 produced by stromal cells, stimulate epithelial cell growth, while TGFβ has the opposite effect. EGF is an autocrine/paracrine factor involved in epithelial cell growth. SCGF, originally found as a growth factor for primitive hematopoetic progenitor cells, was found in the DP [31] , though its function is unknown. The determined values of mRNA of growth factors seem to be very low but should be significant, since the levels are normalized by abundant expression of β-actin. The present data demonstrate that mRNA levels of these growth factors greatly differ among the prostatic lobes, though they are generally lower in the VP. The other androgen dependent genes examined were calreticulin, an intercellular Ca 2+ -binding protein that may be involved in the prevention of apoptosis of prostatic cells [32] , FPPS, an essential enzyme catalyzing the synthesis of farnesyl diphosphate [33] , DAD-1, a defender against apoptotic cell death [7] and ERβ [13] . Several lines of evidence suggest that ERs are involved in regulating cell proliferation and in carcinogenesis in the prostate gland [34, 35] .
To examine androgen-responsive transcription, changes in mRNA levels at one week after castration were first determined. Castration decreased most of the mRNA levels examined, although the degrees of change were most profound in the VP. For instance, probasin expression was almost shut down in the VP by castration, while it remained at one-third of the intact level in the LP and DP, and no change was noted in the AP. The different sensitivities of the lobes to castration might be related to the manner of involution in the different lobes. Androgen abbreviation by castration causes massive apoptotic death of both epithelial and stromal cells in the VP, but it only reduces epithelial cells in the other lobes [36] , so that the cell population could be changed differentially among lobes. However, since the mRNA levels in the present study were normalized to β-actin, the results should be comparable.
To assess the responses more directly regulated by androgen, changes in mRNA levels at 1, 4 and 24 h after testosterone administration were determined. Induction of mRNA within 1 h was found for probasin, EGF, SCGF and calreticulin, which may suggest direct transcriptional regulation through AR. Previous studies have identified AREs in the promoter region of the genes of prostatic proteins. The probasin gene has two distinct AR-binding sites in the 5' flanking region of the genome, both of which are required for androgen responses in in vitro assay [37] . This promoter function probably defines the androgen response of probasin in the VP, though the gene expression could be maintained without androgen in the other lobes. Androgendependent induction of EGF mRNA has been reported in the salivary gland of mice [38] , in addition to the prostate. The 5' flanking region contains several motifs with partial homology to ARE, which may be involved in the transcriptional regulation through AR. Calreticulin protein is expressed abundantly in epithelial cells in the VP [32] . Our results quantitatively confirmed the abundance in terms of mRNA level, which is about 50 times higher that that of β-actin. It was indeed regulated by androgen in the LP/DP/AP, as well as the VP. The regulation of SCGF mRNA seems to be rapidly and tightly regulated by testosterone, since the level was increased at 1 and 4 h and then decreased at 24 h, corresponding to the change in the serum T levels after an injection. ERβ was induced only in the VP. We previously reported that ERβ in the VP was under androgen regulation [13] . Subsequently, the promoter function was identified in the 5'flanking region of the gene and was proved to account for the androgendependent regulation [39] .
In contrast to probasin, the VP secretory proteins prostatein C3, kallikrein S3 and CRP-1 increased only after 24 h, with the mRNA levels remaining far less than the intact control levels, while the serum testosterone level rose well above the intact control level. The prostatein C3 gene contains ARE-like motifs in the upstream region and the first intron, but only the latter apparently accounts for the androgenic responses in in vitro reporter assay [40] . The response may not be due to a direct interaction of AR and the ARE-like motif in vivo. Other androgen-responsive genes examined, including IGF-1, DAD-1 and FPPS, showed similar androgen responses. In summary, with a few exceptions such as probasin in the VP, the transcriptional induction of most of the examined genes was slow and low after a testosterone injection. Castration might cause the reduction of sensitivity to androgen, or more simply, these genes may not be under the direct transcriptional regulation of androgen. The regulation is complex, and may involve androgen-dependent regeneration of prostatic cells.
In conclusion, our present analysis has outlined the lobe and gene specificities of androgen regulation of gene expression in the prostate. Our data indicate that relatively few genes seem to be directly regulated by androgen, even though many of the prostatic proteins have been considered as androgen-dependent. The present results provide a basis for exploration of the biological regulation of individual genes in the rodent prostate, as well as improving our understanding of how rodent models can best be utilized to investigate human prostate disorders.
